Effects of maternal Campylobacter rectus infection on murine placenta, fetal and neonatal survival, and brain development

Journal of Periodontology

Volumn 76, Issue 11 SUPPL., 2005, Pages 2133-2143

  Offenbacher, Steven ^a   Riche E L ^a   Barros, S P ^a,b   Bobetsis, Y A ^a   Lin, D ^a   Beck, J D ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Fetal growth restriction; Inflammation; Periodontitis; Pregnancy

Indexed keywords

GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BRAIN DEVELOPMENT; CAMPYLOBACTER RECTUS; CONTROLLED STUDY; DECIDUA; DISEASE TRANSMISSION; FEMALE; FETUS; FETUS MORTALITY; FOLLOW UP; GESTATION PERIOD; GESTATIONAL AGE; GRAM NEGATIVE INFECTION; GROWTH RETARDATION; HISTOPATHOLOGY; MATERNAL DISEASE; MOUSE; MOUSE STRAIN; MOUTH INFECTION; NEUROANATOMY; NEWBORN; NEWBORN MORTALITY; NONHUMAN; PERIODONTITIS; PLACENTA DISORDER; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; TISSUE SECTION; VERTICAL TRANSMISSION; WHITE MATTER;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER RECTUS; ENCEPHALITIS; FEMALE; FETAL DEATH; FETAL DISEASES; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28644441746     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.11-S.2133     Document Type: Article

References (46)

1. Infant mortality and low birth weight among black and white infants - United States, 1980-2000. MMWR Morb Mortal Wkly Rep 2002;51:589-592.
2. Mathews TJ, Menacker F, MacDorman MF. Infant mortality statistics from the 2001 period linked birth/ infant death data set. Natl Vital Stat Rep 2003;52:1-28.
3. Pietz J, Peter J, Graf R, et al. Physical growth and neurodevelopmental outcome of nonhandicapped low-risk children born preterm. Early Hum Dev 2004; 79:131-143.
4. Osmond C, Barker DJ. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 2000;108(Suppl. 3):545-553.
5. Offenbacher S, Lieff S, Boggess KA, et al. Maternal periodontitis and prematurity: Part 1: Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001;6:164-174.
6. Scannapieco FA, Bush RB, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcomes. A systematic review. Ann Periodontol 2003;8:70-78.
7. Lin D, Smith MA, Elter J, et al. Porphyromonas gingivalis infection in pregnant mice is associated with placental dissemination, an increase in the placental Th1/Th2 cytokine ratio, and fetal growth restriction. Infect Immun 2003;71:5163-5168.
8. Lin D, Smith MA, Champagne C, Elter J, Beck J, Offenbacher S. Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice. Infect Immun 2003;71:5156-5162.
9. Yeo A, Smith MA, Lin D, et al. Campylobacter rectus mediates growth restriction in pregnant mice. J Periodontol 2005;76:551-557.
10. Collins JG, Smith MA, Arnold RR, Offenbacher S. Effects of Escherichia coli and Porphyromonas gingivalis lipopolysaccharide on pregnancy outcome in the golden hamster. Infect Immun 1994;62:4652-4655.
11. Madianos PN, Lieff S, Murtha AP, et al. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. Ann Periodontol 2001;6:175-182.
12. Offenbacher S, Jared HL, O'Reilly PG, et al. Potential pathogenic mechanisms of periodontitis-associated pregnancy complications. Ann Periodontol 1998; 3:233-250.
13. Colle J-H, Falanga PB, Singer M, Hevin B, Milon G. Quantitation of messenger RNA by competitive RT-PCR: A simplified read out assay. J Immunol Methods 1997;210:175-184.
14. Jiang S, Naito M, Kaizu C, et al. Lipopolysaccharide-induced cytokine and receptor expression and neutrophil infiltration in the liver of osteopetrosis (op/op) mutant mice. Liver 2000;20:465-474.
15. Sidman RL, Abervine JB, Pierce ET. Atlas of the Mouse Brain and Spinal Cord. Cambridge, MA: Harvard University Press; 1971:105-112.
16. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute, Inc.; 1996.
17. Dammann O, Kuban KCK, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 2002;8:46-50.
18. Bell MJ, Hallenbeck JM, Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res 2004; 56:541-546.
19. Brask J, Kristensson K, Hill RH. Exposure to interferon-γ during synaptogenesis increases inhibitory activity after a latent period in cultured rat hippocampal neurons. Eur J Neurosci 2004;19:3193-3201.
20. Kollas BB, Hartle HT, Wigdahl B. Effect of γ-interferon on the expression of major histocompatibility complex class I and II gene products in neural cells isolated from the developing human fetal peripheral nervous system. Fetal Diagn Ther 1992;7:62-74.
21. Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: Key pieces of the development puzzle. Science 1994;266:1508-1518.
22. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 2002;23:3-19.
23. Hemberger M, Nozaki T, Masutani M, Cross JC. Differential expression of angiogenic and vasodilatory factors by invasive trophoblast giant cells depending on depth of invasion. Dev Dyn 2003;227:185-191.
24. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-1193.
25. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med 2000;6:589-593.
26. Dempsey LA, Plummer TB, Coombes SL, Platt JL. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 2000;10:467-475.
27. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 2003;101:560-567.
28. Athanassakis I, Aifantis I, Ranella A, Giouremou K, Vassiliadis S. Inhibition of nitric oxide production rescues LPS-induced fetal abortion in mice. Nitric Oxide 1999;3:216-224.
29. Rezai KA, Farrokh-Siar L, Gasyna EM, Ernest JT, van Seventer GA. The effect of type I and II interferons on human fetal retinal pigment epithelium-induced apoptosis in Jurkat T cells. Invest Ophthalmol Vis Sci 2003;44:3130-3134.
30. Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-γ-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1995;1:732-743.
31. Ossina NK, Cannas A, Powers VC, et al. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997;272:16351-16357.
32. Ye P, D'Ercole AJ. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury. Endocrinology 1999;140:3063-3072.
33. Cammer W. Effects of TNF-α on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000;864:213-219.
34. Ladiwala U, Li H, Antel JP, Nalbantoglu J. p53 induction by tumor necrosis factor-α and involvement of p53 in cell death of human oligodendrocytes. J Neurochem 1999;73:605-611.
35. Buntinx M, Moreels M, Vandenabeele F, et al. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-γ and TNF-α on apoptosis. J Neurosci Res 2004; 76:834-845.
36. Cai Z, Pan Z-L, Pang Y, Evans OB, Rhodes PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64-72.
37. Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia. Pediatr Neurol 1996;14: 13-16.
38. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona A-M, Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001; 56:1278-1284.
39. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002;22: 106-132.
40. Lehnardt S, Lachance C, Patrizi S, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002;22:2478-2486.
41. Shapira L, Ayalon S, Brenner T. Effects of Porphyromonas gingivalis on the central nervous system: Activation of glial cells and exacerbation of experimental autoimmune encephalomyelitis. J Periodontol 2002;73:511-516.
42. Cai Z, Pang Y, Lin S, Rhodes PG. Differential roles of tumor necrosis factor-α and interleukin-1β in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 2003;975:37-47.
43. Levy O, Jean-Jacques RM, Cywes C, et al. Critical role of the complement system in group B Streptococcus-induced tumor necrosis factor alpha release. Infect Immun 2003;71:6344-6353.
44. El-Harith el-HA. The cytokine TNF-alpha. Genetics and suitability for prenatal risk assessment. Saudi Med J 2004;25:135-140.
45. Ha DH, Robertson RT, Ribak CE, Weiss JH. Cultured basal forebrain cholinergic neurons in contact with cortical cells display synapses, enhanced morphological features, and decreased dependence on nerve growth factor. J Comp Neurol 1996;373:451-465.
46. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989;341:149-152.